Jeffrey Farber elected VP of Lannett
This article was originally published in Scrip
Executive Summary
Generics pharmaceutical company Lannett has elected Jeffrey Farber vice-president of the board. Mr Farber has been a member of Lannett's board since 2006, and is the founder and president of Auburn Pharmaceutical.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.